Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MC230601 Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

NCT07062016 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07062016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07062016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MC230601 Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2025
Completion date
October 31, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial carcinoma, endometrial high grade endometrioid adenocarcinoma, stage ii endometrial cancer, stage iii endometrial cancer, stage iv endometrial cancer